Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02247765 · ClinicalTrials.gov registry record · Phase 3
Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion
A Phase 3 study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 3
- Development phase
- 18
- Enrollment target
NCT02247765: Completed Phase 3 study, sponsored by Medtronic - MITG.
NCT02247765 is a Phase 3 study that has completed, run by Medtronic - MITG. The registered enrollment target is 18 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02247765, a Phase 3 study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 18 participants
- Enrollment target
Study Summary
To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.
Primary Outcome
For each range specified, SpO2 accuracy of the pulse oximeter equipment is stated in terms of the Accuracy Root-Mean-Square (ARMS) difference between measured values (SpO2) and reference blood values (SaO2). The MaxA sensors has a different bandage from the MaxN sensor, and therefore a different form and fit.
Interventions
- DEVICE Arterial line
- DEVICE Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 3 |
What the finished NCT02247765 record still lists
NCT02247765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Arterial line is the first listed.
NCT02247765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02247765 about?
NCT02247765 is a clinical study titled "Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion". To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.
What is the current status of trial NCT02247765?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2014-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02247765?
The interventions under investigation include: Arterial line (DEVICE), Motion (DEVICE).
Who is sponsoring clinical trial NCT02247765?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02247765's enrollment target sits among peer trials
18 1970th of 2000 higher than 30 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia